Genmab A/S ADR (GMAB)
20.00 x 2 21.25 x 1
Post-market by (Cboe BZX)
20.79 +0.16 (+0.78%) 04/29/25 [NASDAQ]
20.00 x 2 21.25 x 1
Post-market 20.79 unch (unch) 16:01 ET
for Tue, Apr 29th, 2025
Results
download Want to compare other data? Select Fields| Symbol | GMAB | BIIB | INSM | ||
| Company | Genmab A/S ADR | Biogen Inc | Insmed Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 21.04 | 117.96 | 69.66 | ||
| High | 21.08 | 121.17 | 72.15 | ||
| Low | 20.75 | 116.63 | 69.20 | ||
| Last | 20.79 | 120.17 | 71.40 | ||
| Change | +0.16 | +1.05 | +1.54 | ||
| % Change | +0.78% | +0.88% | +2.20% | ||
| Volume | 1,230,981 | 995,594 | 1,846,116 | ||
| 20-Day Average Volume | 1,573,074 | 1,806,125 | 3,034,436 | ||
| Previous Close | 20.63 | 119.12 | 69.86 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 19.42 | 120.03 | 69.92 | ||
| 20-Day Raw Stochastic | 92.45% | 37.13% | 72.13% | ||
| 20-Day Relative Strength | 55.32% | 41.44% | 48.06% | ||
| Weighted Alpha | -27.63 | -47.33 | +22.13 | ||
| Today's Opinion | 48% Sell | 88% Sell | 24% Sell | ||
| Previous Opinion | 72% Sell | 100% Sell | 40% Sell | ||
| Last Month's Opinion | 88% Sell | 72% Sell | 56% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +2.57% since 04/22/25 | +1.08% since 04/22/25 | +0.22% since 04/22/25 | ||
| Low | 20.02 on 04/23/25 | 116.63 on 04/29/25 | 66.43 on 04/24/25 | ||
| High | 21.08 on 04/29/25 | 121.75 on 04/23/25 | 72.71 on 04/23/25 | ||
| 1-Month | |||||
| %Chg | +4.47% since 03/28/25 | -13.15% since 03/28/25 | -8.45% since 03/28/25 | ||
| Low | 17.24 on 04/09/25 | 110.04 on 04/09/25 | 60.40 on 04/09/25 | ||
| High | 21.08 on 04/29/25 | 138.00 on 03/31/25 | 76.70 on 03/31/25 | ||
| 3-Month | |||||
| %Chg | +4.74% since 01/29/25 | -16.79% since 01/29/25 | -8.46% since 01/29/25 | ||
| Low | 17.24 on 04/09/25 | 110.04 on 04/09/25 | 60.40 on 04/09/25 | ||
| High | 24.33 on 03/07/25 | 157.09 on 03/10/25 | 84.91 on 02/21/25 | ||
| 6-Month | |||||
| %Chg | -10.08% since 10/29/24 | -34.50% since 10/29/24 | +0.63% since 10/29/24 | ||
| Low | 17.24 on 04/09/25 | 110.04 on 04/09/25 | 60.40 on 04/09/25 | ||
| High | 24.33 on 03/07/25 | 185.00 on 10/30/24 | 84.91 on 02/21/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 13,228,038 | 17,436,190 | 12,701,946 | ||
| Shares Outstanding, K | 641,204 | 146,375 | 181,820 | ||
| Annual Sales | 3,121,270,000 | 9,675,900,000 | 363,710,000 | ||
| Annual Net Income | 1,137,380,000 | 1,632,200,000 | -913,770,000 | ||
| Last Quarter Sales | 921,940,000 | 2,454,700,000 | 104,440,000 | ||
| Last Quarter Net Income | 554,680,000 | 266,700,000 | -235,550,000 | ||
| 60-Month Beta | 1.07 | 0.06 | 1.07 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.57 on 02/12/25 | 3.44 on 02/12/25 | -1.32 on 02/20/25 | ||
| Latest Earnings Date | 05/08/25 | 05/01/25 | 05/08/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 16.60 | 7.22 | 0.00 | ||